These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 17190527

  • 21. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
    Dunk LR, Annan LJ, Andrews CD.
    Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
    [Abstract] [Full Text] [Related]

  • 22. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S.
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract] [Full Text] [Related]

  • 23. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL, Yim PH.
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [Abstract] [Full Text] [Related]

  • 24. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
    Sperner-Unterweger B, Czeipek I, Gaggl S, Geissler D, Spiel G, Fleischhacker WW.
    Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
    [Abstract] [Full Text] [Related]

  • 25. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF.
    J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
    [Abstract] [Full Text] [Related]

  • 26. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW, Bogers JP, Giltay EJ.
    Gen Hosp Psychiatry; 2013 Apr; 35(5):576.e11-2. PubMed ID: 23395419
    [Abstract] [Full Text] [Related]

  • 27. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP.
    Tijdschr Psychiatr; 2007 Apr; 49(8):575-9. PubMed ID: 17694491
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of clozapine-induced granulocytopenia with lithium (two observations)].
    Papetti F, Darcourt G, Giordana JY, Spreux A, Thauby S, Feral F, Pringuey D.
    Encephale; 2004 Apr; 30(6):578-82. PubMed ID: 15738861
    [Abstract] [Full Text] [Related]

  • 29. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
    Béchard L, Corbeil O, Plante M, Thivierge MA, Lafrenière CÉ, Roy MA, Demers MF.
    J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
    [Abstract] [Full Text] [Related]

  • 30. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, Gochman P, Rapoport JL.
    J Child Adolesc Psychopharmacol; 2003 Sep; 13(3):401-4. PubMed ID: 14642024
    [Abstract] [Full Text] [Related]

  • 31. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG, Stewart JT.
    South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
    [Abstract] [Full Text] [Related]

  • 32. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J.
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [Abstract] [Full Text] [Related]

  • 33. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
    Chan KSW, Lai NBW, Wong MMC, Pang PF.
    East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
    [Abstract] [Full Text] [Related]

  • 34. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G, Lillo-Le Louet A, Darnige L, Loo H, Krebs MO.
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [Abstract] [Full Text] [Related]

  • 35. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K, Ishibashi M, Kawano M, Oshibuchi H, Ishigooka J, Nishimura K, Inada K.
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [Abstract] [Full Text] [Related]

  • 36. Haematological side effects of clozapine: patient characteristics.
    Miller PR, Cutten AE.
    N Z Med J; 1997 Apr 11; 110(1041):125-7. PubMed ID: 9140414
    [Abstract] [Full Text] [Related]

  • 37. Continuing clozapine treatment despite neutropenia.
    Esposito D, Rouillon F, Limosin F.
    Eur J Clin Pharmacol; 2005 Jan 11; 60(11):759-64. PubMed ID: 15660271
    [Abstract] [Full Text] [Related]

  • 38. Clozapine Rechallenge After Neutropenia or Leucopenia.
    Prokopez CR, Armesto AR, Gil Aguer MF, Balda MV, Papale RM, Bignone IM, Daray FM.
    J Clin Psychopharmacol; 2016 Aug 11; 36(4):377-80. PubMed ID: 27232877
    [Abstract] [Full Text] [Related]

  • 39. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.
    Béchard L, Morasse-Bégis M, Corbeil O, Hakim JR, Malenfant E, Brodeur S, Huot-Lavoie M, Essiambre AM, Demers MF, Roy MA.
    J Clin Psychopharmacol; 2016 Aug 11; 42(4):391-395. PubMed ID: 35546087
    [Abstract] [Full Text] [Related]

  • 40. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ, Ramlal D.
    Tijdschr Psychiatr; 2012 Aug 11; 54(9):829-33. PubMed ID: 22961282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.